Skip to main content
SpringerLink
Log in

Prävention der koronaren Herzerkrankung

Prevention of coronary artery disease

  • Schwerpunkt: Prävention in der Inneren Medizin
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Atherosklerotische Gefäßerkrankungen im Allgemeinen und die koronare Herzerkrankung im Besonderen sind in westlichen Industrienationen die häufigsten Ursachen für den Verlust der Leistungsfähigkeit, die Verminderung der Lebensqualität und vorzeitigen Tod. Obwohl es sich in den meisten Fällen um vermeidbare Erkrankungen handelt, ist ihre Häufigkeit in den westlich industrialisierten Ländern immer noch inakzeptabel. Bei konsequenter Umsetzung der Empfehlungen zur Prävention zu den Lebensstilaspekten Rauchen, Ernährung, Gewicht und körperliche Aktivität könnten bereits mehr als die Hälfte der atherosklerotischen Erkrankungen in der Bundesrepublik vermieden werden. Diese Übersichtsarbeit zur Prävention der koronaren Herzerkrankungen soll deshalb die wichtigsten Risikofaktoren für diese Erkrankungen in der Allgemeinbevölkerung benennen, ihre Pathophysiologie beleuchten und Wege zu deren Reduktion aufzeigen.

Abstract

Coronary artery disease is still the leading cause of premature death, reduction in physical work capacity and diminished quality of life in western civilizations. Given the fact that coronary artery disease is a preventable disease in most of the cases, its prevalence remains unacceptably high. Consequent application of preventive recommendations with regards to life-style aspects like tobacco use, nutrition, overweight and physical activity could help to reduce the prevalence of atherosclerotic diseases by half. Aim of this review is to focus the reader’s attention to the most important risk factors, their influence on progression of atherosclerotic lesions and ways to reduce risk factor burden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Adams V, Linke A, Kränkel N et al.(2005). Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 111: 555–562

    Article  PubMed  CAS  Google Scholar 

  2. Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43: 1731–1737

    Article  PubMed  CAS  Google Scholar 

  3. Arzneimittelkommission der deutschen Ärzteschaft (2003) Deutschland ist Europameister – sowohl bei der Häufigkeit als auch in der mangelhaften Kontrolle des Bluthochdrucks. AkdÄ Newsletter 040/03

  4. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105: 310–315

    Article  PubMed  Google Scholar 

  5. Barua RS, Ambrose JA, Saha DC et al. (2002) Smoking is associated with altered endothelialderived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation 106: 905–908

    Article  PubMed  Google Scholar 

  6. Berenson GS, Srinivasan SR, Bao W et al. (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338: 1650–1566

    Article  PubMed  CAS  Google Scholar 

  7. Bergmann KE, Mensink GBM (1999) Körpermaße und Übergewicht. Gesundheitswesen 61: S115–S120

    PubMed  Google Scholar 

  8. Booth FW, Gordon SE, Carlson CJ et al. (2000) Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol 88: 774–787

    PubMed  CAS  Google Scholar 

  9. Chapman MJ, Assmann G, Fruchart JC et al. European Consensus Panel on HDL-C (2004) Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European consensus panel on HDL-C. Curr Med Res Opin 20: 1253–1268

    Article  PubMed  CAS  Google Scholar 

  10. Choi D, Kim SK, Choi SH et al. (2004) Preventive effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 27: 2654–2660

    Article  PubMed  CAS  Google Scholar 

  11. Conroy RM, Pyörälä K, Fitzgerald AP et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987–1003

    Article  PubMed  CAS  Google Scholar 

  12. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194

    Article  PubMed  CAS  Google Scholar 

  13. Deutsche Gesellschaft für Prävention und Rehabilitation Herz-Kreislauferkrankungen e.V., Deutsche Gesellschaft für Rehabilitationswissenschaften e.V., Deutsche Gesellschaft für Sportmedizin und Prävention e.V. (2007) Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha). Clin Res Cardiol (Suppl 2): III/1–III/54

    Google Scholar 

  14. EUROASPIRE I and II Group: European Action on Secondary Prevention by Intervention to Reduce Events (2001) Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 357: 995–1001

    Article  Google Scholar 

  15. EUROASPIRE II Study Group (2001) Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries, principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22: 554–572

    Article  Google Scholar 

  16. Gohlke H, Schuler G (2003) Empfehlungen zur Prävention und evidenzbasierte Medizin. Z Kardiol 92: 522–524

    PubMed  CAS  Google Scholar 

  17. Grundy SM, Hansen B, Smith SC et al.(2004) Clinical management of metabolic syndrome. Circulation 109: 551–556

    Article  PubMed  Google Scholar 

  18. Hambrecht R, Adams V, Erbs S et al. (2003). Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107: 3152–3158

    Article  PubMed  CAS  Google Scholar 

  19. Hambrecht R, Wolff A, Gielen S et al. (2000) Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342: 454–460

    Article  PubMed  CAS  Google Scholar 

  20. Haskell WL, Lee IM, Pate RR et al. American College of Sports Medicine; American Heart Association (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116: 1081–1093

    Article  PubMed  Google Scholar 

  21. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,535 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22

    Article  Google Scholar 

  22. Heidrich J, Liese AD, Kalic M et al. (2002) Sekundärprävention der koronaren Herzkrankheit – Ergebnisse der Euroaspire I- und II-Studien in der Region Münster, Germany. Dtsch Med Wochenschr 127: 667–672

    Article  PubMed  CAS  Google Scholar 

  23. Kavey RE, Daniels SR, Lauer RM et al. American Heart Association (2003) American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107: 1562–1566

    Article  PubMed  Google Scholar 

  24. Kopelman PG (2000) Physiopathology of prolactin secretion in obesity. Int J Obes Relat Metab Disord 24 (Suppl 2): S104–108

    PubMed  CAS  Google Scholar 

  25. Kuhlmann E (2003) Gender Mainstreaming in den Disease Management Programmen – Das Beispiel Koronare Herzerkrankung. http://www.zes.uni-bremen.de/~kuhlmann/expertise.pdf

  26. Laufs U, Werner N, Link A et al. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220–226

    Article  PubMed  CAS  Google Scholar 

  27. Lavie CJ, Milani RV (1997) Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 79: 397–401

    Article  PubMed  CAS  Google Scholar 

  28. Löwel H, Stieber J, Koenig W et al. (1999) Das Diabetes-bedingte Herzinfarktrisiko in einer süddeutschen Bevölkerung: Ergebnisse der MONICA-Augsburg-Studien 1985–1994. Diabetes Stoffw 8: 11–21

    Google Scholar 

  29. Moschandreas J, Kafatos A, Aravanis C et al. (2005) Long-term predictors of survival for the Seven Countries Study cohort from Crete: from 1960 to 2000. Int J Cardiol 100: 85–91

    Article  PubMed  Google Scholar 

  30. Paffenbarger RS, Hyde RT, Wing AL et al. (1986) Physical activity, all cause mortality, and longevity of college alumni. N Engl J Med 314: 605–613

    Article  PubMed  Google Scholar 

  31. Pearson TA, Blair SN, Daniels SR et al. (2002) AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106: 388–391

    Article  PubMed  Google Scholar 

  32. Perticone F, Ceravolo R, Pujia A (2001)Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104: 191–196

    PubMed  CAS  Google Scholar 

  33. Pietinen P, Vartiainen E, Korhonen HJ et al. (1989) Nutrition as a component in community control of cardiovascular disease (the North Karelia Project). Am J Clin Nutr 49 (Suppl): 1017–1024

    PubMed  CAS  Google Scholar 

  34. Rosengreen A, Hawken S, Ounpuu S et al. (2004)Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case control study. Lancet 364: 953–962

    Article  Google Scholar 

  35. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809

    Article  PubMed  CAS  Google Scholar 

  36. Sandri M, Adams V, Gielen S et al. (2005) Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111: 3391–3339

    Article  PubMed  Google Scholar 

  37. Schächinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899–1906

    PubMed  Google Scholar 

  38. Siegrist J (2006) Was trägt die Stressforschung zur Erklärung des sozialen Gradienten koronarer Herzkrankheit bei? Dtsch Med Wochenschr 131: 762–766

    Article  PubMed  CAS  Google Scholar 

  39. Statistisches Bundesamt Deutschland (2004) Pressemitteilung vom 24.09.2004. http://www.destatis.de/presse/deutsch/pm2004/p4060092.htm

  40. Statistisches Bundesamt Deutschland (2006) Gesundheitswesen. http://www.destatis.de/basi/d/gesu/gesutab19.php

  41. Strauer BE (1992)The concept of coronary flow reserve. J Cardiovasc Pharmacol 19 (Suppl 5): 67–80

    Article  Google Scholar 

  42. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853

    Article  Google Scholar 

  43. Virtanen KA, Hällsten K, Parkkola R et al. (2003) Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetes subjects. Diabetes 52: 283–290

    Article  PubMed  CAS  Google Scholar 

  44. World Health Organization (1999) Obesity. Preventing and managing the global epidemic. WHO, Geneva, p 276

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin/ Kardiologie, Universität Leipzig – Herzzentrum, Strümpellstraße 39, 04289, Leipzig, Deutschland

    M. Sandri, S. Gielen &  G. Schuler

Authors
  1. M. Sandri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Gielen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Schuler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Schuler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandri, M., Gielen, S. & Schuler, G. Prävention der koronaren Herzerkrankung. Internist 49, 154–161 (2008). https://doi.org/10.1007/s00108-007-1995-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-007-1995-6

Schlüsselwörter

Keywords

Search

Navigation